Viewing Study NCT02182232


Ignite Creation Date: 2025-12-24 @ 9:33 PM
Ignite Modification Date: 2026-01-09 @ 7:59 AM
Study NCT ID: NCT02182232
Status: COMPLETED
Last Update Posted: 2014-07-18
First Post: 2014-07-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module